The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes

被引：13
作者：
Norgaard, Caroline Holm [1 ,2 ]
Mosslemi, Mitra [2 ]
Lee, Christina J. -Y. [1 ]
Torp-Pedersen, Christian [1 ,3 ,4 ]
Wong, Nathan D. [2 ,5 ]
机构：
[1] Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark
[2] Univ Calif Irvine, Heart Dis Prevent Program, Irvine, CA 92697 USA
[3] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark
[4] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[5] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA
来源：
CURRENT CARDIOLOGY REPORTS | 2019年 / 21卷 / 05期
关键词：
Risk factor control; Cardiovascular disease; Type; 2; diabetes; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; BLOOD-PRESSURE CONTROL; 10-YEAR FOLLOW-UP; CARDIOVASCULAR-DISEASE; MULTIFACTORIAL INTERVENTION; GLUCOSE CONTROL; US ADULTS; MORTALITY; OUTCOMES;
D O I：
10.1007/s11886-019-1123-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose of ReviewThe importance of composite risk factor control for reducing CVD risk in type 2 diabetes (T2DM) has gained increased attention and here we review the latest findings in the field.Recent FindingsThe Steno-2 study was the first to show that early intensive risk factor control could improve risk factor status and halve the CVD risk in patients with diabetes with lasting impact. A range of observational studies have added further insight to the importance of multiple risk factor control showing an incremental association between number of risk factors controlled and reduction in CVD risk. Noteworthy, a Swedish population-based study recently showed that optimal risk factor status in patients with T2DM was associated with a CVD risk similar to the general population.SummaryEarly intensive intervention to achieve optimal risk factor control reduces CVD risk and should be of principal focus in T2DM management.
引用
收藏
页数：10
相关论文
共 81 条
[11]  
[Anonymous], 2016, LANCET, DOI DOI 10.1016/S0140-6736(15)01225-8
[12]  
[Anonymous], 2021, IDF Diabetes Atlas
[13]  
[Anonymous], 2018, 2018 AHA ACC AACVPR
[14]  
[Anonymous], DIABETES RES CLIN S
[15]   Comprehensive Cardiovascular Risk Factor Control Improves Survival The BARI 2D Trial [J].
Bittner, Vera ;
Bertolet, Marnie ;
Felix, Rafael Barraza ;
Farkouh, Michael E. ;
Goldberg, Suzanne ;
Ramanathan, Kodangudi B. ;
Redmon, J. Bruce ;
Sperling, Laurence ;
Rutter, Martin K. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (07) :765-773
[16]   Cardiovascular Outcomes in Framingham Participants With Diabetes The Importance of Blood Pressure [J].
Chen, Guanmin ;
McAlister, Finlay A. ;
Walker, Robin L. ;
Hemmelgarn, Brenda R. ;
Campbell, Norm R. C. .
HYPERTENSION, 2011, 57 (05) :891-U65
[17]   Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS) [J].
Chiang, Chern-En ;
Ferrieres, Jean ;
Gotcheva, Nina N. ;
Raal, Frederick J. ;
Shehab, Abdulla ;
Sung, Jidong ;
Henriksson, Karin M. ;
Hermans, Michel P. .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (05) :567-587
[18]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[19]  
Collins R, 2003, LANCET, V361, P2005
[20]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
123456789